News
Dopamine Agonists, DRIs Similar for QoL in Parkinson Disease
No measurable difference in patient-rated quality of life seen for dopamine agonists versus dopamine reuptake inhibitors as adjuvant therapy
Your search for parkinsonism returned 387 results
Drugs in the Pipeline
Novel Pramipexole-Rasagiline Combo Promising for Early Parkinson Disease
The fixed-dose combination therapy was found to be superior to each component.
News
AAN Updates Recommendations for Early Parkinson Disease Treatment
Counseling should be provided to individuals with early Parkinson disease on the benefits and risks of initiating treatment.
News
Focused Ultrasound Device Approved for Advanced Parkinson Disease
Patients are awake and responsive during the whole treatment duration.
Drugs in the Pipeline
Continuous SC Infusion Therapy Bests Oral Levodopa/Carbidopa in Parkinson Trial
The randomized, double-blind, double-dummy, active-controlled study compared ABBV-951 via continuous SC infusion to oral levodopa/carbidopa.
News
Oral Inosine Does Not Slow Progression of Early Parkinson Disease
No significant difference seen in rate of clinical disease progression or in secondary efficacy outcomes versus placebo
News
Invega Hafyera Approved for Twice-Yearly Treatment of Schizophrenia
The Food and Drug Administration has approved Invega Hafyera™ (paliperidone palmitate), an every 6-month injection, for the treatment of schizophrenia in adults. Invega Hafyera is a long-acting atypical antipsychotic that is administered as a gluteal intramuscular injection by a health care professional. Prior to initiating treatment with Invega Hafyera, patients must have been adequately treated…
Clinical Charts
Psychotropic Drug Indications
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
Clinical Charts
Neurogenic Orthostatic Hypotension: Screening & Diagnosis
Expert panel recommendations on the screening and step-wise diagnosis of neurogenic orthostatic hypotension (nOH).
News
Relapse Risk for Psychosis in Dementia Lower With Continued Pimavanserin
Findings seen in double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy
